VINP (VINP) Stock Price & Analysis

VINP (VINP) fell 0.11% to USD 9.51 as of July 25, 2026 at 04:57 UTC, according to Nexqual real-time market data.

VINP last closed at USD 9.52; the session ranged USD 9.45–9.67 on volume of 26,925 shares. Market capitalization is $623.06M, with a 52-week range of USD 9.29–13.61 (NMS). Source: Nexqual, July 25, 2026 at 04:57 UTC.

Key Statistics (as of July 25, 2026 at 04:57 UTC)

PriceUSD 9.51
Change▼ 0.11% (down)
Previous CloseUSD 9.52
OpenUSD 9.53
Day RangeUSD 9.45 – 9.67
52-Week RangeUSD 9.29 – 13.61
Volume26,925 shares
Market Cap$623.06M
ExchangeNMS

Technical Analysis (VINP)

Nexqual's technical model rates VINP "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 04:57 UTC.

Overall SignalSELL
RSI (14)42.52 (neutral)
vs SMA50Below (USD 9.89)
MACD-0.09 (negative)

Analyst Ratings (VINP)

Wall Street analysts rate VINP "Strong Buy" based on 6 analysts, with a mean price target of USD 14.02 (range USD 12.12–15.46), per Nexqual as of July 25, 2026 at 04:57 UTC.

Consensus RatingStrong Buy
Analyst Count6
Mean TargetUSD 14.02
High TargetUSD 15.46
Low TargetUSD 12.12
Buy / Hold / Sell6 / 0 / 0

Earnings (VINP)

Next Earnings Date2026-08-11
EPS EstimateUSD 1.08
Revenue Estimate$286.25M

Recent Earnings History

QuarterActual vs Estimate
2026-03-31USD 0.74 vs est 1.09 ▼ miss
2025-12-31USD 1.5 vs est 1.26 ▲ beat
2025-09-30USD 0.89 vs est 1.03 ▼ miss
2025-06-30USD 0.86 vs est 1.11 ▼ miss

Source: Nexqual, July 25, 2026 at 04:57 UTC.

Financials & Fundamentals (VINP)

Total Revenue$1.02B
Revenue Growth (YoY)+17.10%
Gross Margin+100.00%
Operating Margin+31.39%
Profit Margin+25.95%
ROE+13.72%
Debt / Equity49.89
Current Ratio5.08
Total Cash$964.25M
Total Debt$1.04B
Free Cash Flow$147.34M

Source: Nexqual, July 25, 2026 at 04:57 UTC.

Financial Health Score (VINP)

Nexqual rates VINP's overall financial health "Strong" across five dimensions, as of July 25, 2026 at 04:57 UTC.

GrowthStrong — Revenue +63% YoY (annual)
ProfitabilityStrong — Operating margin 31%
Balance SheetStrong — $964M cash vs $1.04B debt
Cash FlowStrong — FCF $147M, 15% margin
EfficiencyMixed — ROE 14%, ROA 4.8%

Ownership (VINP)

Insider Ownership+47.21%
Institutional Ownership+21.15%
Shares Outstanding51.05M
Float21.84M
Short % of Float+1.22%

Source: Nexqual, July 25, 2026 at 04:57 UTC.

Leadership (VINP)

VINP is led by Alessandro Monteiro Morgado Horta (age 55), CEO & Director, per Nexqual as of July 25, 2026 at 04:57 UTC.

CEO & DirectorAlessandro Monteiro Morgado Horta (age 55)
COO & CFOSergio Passos Ribeiro (age 49)
President of Finance & OperationsBruno Augusto Sacchi Zaremba C.F.A. (age 48)

Major Backers & Investors (VINP)

Notable institutional backers of VINP include SPX Gestao de Recursos Ltda, Samlyn Capital, LLC, UBS Group AG, according to Nexqual as of July 25, 2026 at 04:57 UTC.

Active Investors

InvestorStake
SPX Gestao de Recursos Ltda9.17%
Samlyn Capital, LLC4.74%
UBS Group AG0.79%
Endure Capital Management, LLC0.66%
JPMorgan0.61%
Goldman Sachs0.61%
Rockefeller Capital Management L.P.0.24%
Deltec Asset Management LLC0.23%

Index Funds (Passive)

FundStake
BlackRock1.32%
State Street0.38%

Source: Nexqual, July 25, 2026 at 04:57 UTC.

Peers & Related Stocks

SymbolNamePriceChange
FTHMFathom Holdings Inc.USD 0.85▼ 2.3%
OMOutset Medical, Inc.USD 4.04▼ 2.18%
CGEMCullinan Therapeutics, Inc.USD 17.1▼ 3.12%
PAXPatria Investments LimitedUSD 10.8▼ 1.19%
IMCRImmunocore Holdings plcUSD 35▼ 1.52%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 04:57 UTC. This page is informational and not investment advice.